{"title":"Aerogen","description":null,"products":[{"product_id":"aerogen-pro-x-controller-power-source","title":"Aerogen Pro-X Controller Power Source","description":"\u003cp\u003eThe Aerogen Pro-X Controller is the power and control unit used with compatible Aerogen Solo and Aerogen Ultra nebulisers. It supports efficient aerosol delivery in hospital, transport and homecare environments.\u003c\/p\u003e\u003ch3\u003eKey features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuiet operation using Aerogen vibrating-mesh technology\u003c\/li\u003e\n\u003cli\u003e30-minute and continuous operating modes\u003c\/li\u003e\n\u003cli\u003eRechargeable for portable use\u003c\/li\u003e\n\u003cli\u003eClear LED status indicators\u003c\/li\u003e\n\u003cli\u003eSuitable for ventilated, non-ventilated and spontaneously breathing patients when configured with compatible Aerogen equipment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eCompatibility\u003c\/h3\u003e\u003cp\u003eFor use with Aerogen Solo and Aerogen Ultra nebulisers. Check the required nebuliser, cable and patient interface before ordering.\u003c\/p\u003e","brand":"AEROGEN","offers":[{"title":"Default Title","offer_id":54981250482556,"sku":"AG-PX1000-AG","price":1020.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0628\/9575\/1325\/files\/image_ea4184f2-f48a-414b-a0b0-e2c17bf40601.jpg?v=1740658420"},{"product_id":"aerogen-pro-x-controller-power-source-ex-vat","title":"Aerogen Pro-X Controller Power Source","description":"\u003cp\u003eThe Aerogen Pro-X Controller is the power and control unit used with compatible Aerogen Solo and Aerogen Ultra nebulisers. It supports efficient aerosol delivery in hospital, transport and homecare environments.\u003c\/p\u003e\u003ch3\u003eKey features\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eQuiet operation using Aerogen vibrating-mesh technology\u003c\/li\u003e\n\u003cli\u003e30-minute and continuous operating modes\u003c\/li\u003e\n\u003cli\u003eRechargeable for portable use\u003c\/li\u003e\n\u003cli\u003eClear LED status indicators\u003c\/li\u003e\n\u003cli\u003eSuitable for ventilated, non-ventilated and spontaneously breathing patients when configured with compatible Aerogen equipment\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch3\u003eCompatibility\u003c\/h3\u003e\u003cp\u003eFor use with Aerogen Solo and Aerogen Ultra nebulisers. Check the required nebuliser, cable and patient interface before ordering.\u003c\/p\u003e","brand":"AEROGEN","offers":[{"title":"Default Title","offer_id":54981250548092,"sku":"AG-PX1000-AG","price":850.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0628\/9575\/1325\/files\/image_79529f6e-64f6-42d5-a357-3a1deb193220.jpg?v=1740658423"},{"product_id":"aerogen-solo-nebuliser","title":"Aerogen Solo Nebuliser","description":"\u003ch3\u003eThe Aerogen Solo Nebuliser Chamber is sold in pack 10 units\u003c\/h3\u003e\n\u003ch3\u003eEffectiveness\u003c\/h3\u003e\n\u003ch4\u003eAerogen facilitates effective medication delivery across multiple respiratory modalities\u003csup\u003e3-8†\u003c\/sup\u003e\n\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eIn studies, ~4x more drug deposition was achieved with Aerogen during IMV,\u003csup\u003e†3,4\u003c\/sup\u003e NIV\u003csup\u003e‡5\u003c\/sup\u003e, and HF,\u003csup\u003e6\u003c\/sup\u003e and ~6x more drug deposition during SV\u003csup\u003e‡7\u003c\/sup\u003e versus jet nebulisers\u003csup\u003e\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\n\u003csup\u003e†\u003c\/sup\u003eWhen placed 15 cm from the Y-Piece in a heated setting; in-vitro model\u003cbr\u003e\u003csup\u003e‡\u003c\/sup\u003eStudy performed in healthy subjects \u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cmeta charset=\"UTF-8\"\u003e\n\u003ch3\u003ePatient care\u003c\/h3\u003e\n\u003ch4\u003eAerogen improves patient care in response to aerosolised medication\u003csup\u003e9-11\u003c\/sup\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003eIn studies assessing bronchodilator delivery across several respiratory modalities, Aerogen Solo, when compared with jet nebulisers, was associated with:\u003c\/span\u003e\n\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eImprovements in lung function in patients undergoing NIV\u003csup\u003e†9\u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eComparable bronchodilator efficacy\u003csup\u003e‡ \u003c\/sup\u003eduring HF\u003csup\u003e10\u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eReductions in hospital admission rates, emergency department median length of stay, and in the number of treatments and time required to achieve symptom control\u003csup\u003e§ \u003c\/sup\u003e in SV patients\u003csup\u003e¶11 \u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003csup\u003e†\u003c\/sup\u003eBetween-group difference in FEV\u003csub\u003e1\u003c\/sub\u003e, FVC, breathlessness score, RR, and PaCO\u003csub\u003e2\u003c\/sub\u003e from  baseline to 120 minutes in patients with acute exacerbation of COPD\u003cbr\u003e\u003csup\u003e‡\u003c\/sup\u003eAs defined by relative increase in FEV\u003csub\u003e1\u003c\/sub\u003e in patients with reversible obstructive lung disease\u003cbr\u003e\u003csup\u003e§\u003c\/sup\u003eDefined as achieving a mild asthma score following an asthma exacerbation\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWorkflow\u003c\/h3\u003e\n\u003ch4\u003eAerogen simplifies the workflow\u003c\/h4\u003e\n\u003cdiv\u003e\n\u003cul\u003e\n\u003cli\u003eAerogen Solo is a closed-circuit aerosol drug delivery system,\u003csup\u003e2\u003c\/sup\u003e which eliminates the need to open the circuit when administering medication during IMV or NIV  \u003c\/li\u003e\n\u003cli\u003eAerogen Solo delivers integrated aerosol delivery with HF and can be used in conjunction with Aerogen Ultra for aerosol drug delivery in SV patients\u003csup\u003e2\u003c\/sup\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAerogen Solo is intended for the aerosolisation of physician-prescribed medications for inhalation which are approved for use with a general purpose nebuliser\u003csup\u003e2\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003eOne system can be used throughout a patient's respiratory journey (IMV, NIV, HF, SV),\u003csup\u003e2\u003c\/sup\u003e supporting continuity of care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AEROGEN","offers":[{"title":"Default Title","offer_id":54981251400060,"sku":"AG-AS3200","price":546.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0628\/9575\/1325\/files\/image_e28c132a-5410-435b-968c-8ac4eddccbfe.jpg?v=1740658430"},{"product_id":"aerogen-solo-nebuliser-ex-vat","title":"Aerogen Solo Nebuliser","description":"\u003ch3\u003eThe Aerogen Solo Nebuliser Chamber is sold in pack 10 units\u003c\/h3\u003e\n\u003ch3\u003eEffectiveness\u003c\/h3\u003e\n\u003ch4\u003eAerogen facilitates effective medication delivery across multiple respiratory modalities\u003csup\u003e3-8†\u003c\/sup\u003e\n\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003eIn studies, ~4x more drug deposition was achieved with Aerogen during IMV,\u003csup\u003e†3,4\u003c\/sup\u003e NIV\u003csup\u003e‡5\u003c\/sup\u003e, and HF,\u003csup\u003e6\u003c\/sup\u003e and ~6x more drug deposition during SV\u003csup\u003e‡7\u003c\/sup\u003e versus jet nebulisers\u003csup\u003e\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv\u003e\n\u003csup\u003e†\u003c\/sup\u003eWhen placed 15 cm from the Y-Piece in a heated setting; in-vitro model\u003cbr\u003e\u003csup\u003e‡\u003c\/sup\u003eStudy performed in healthy subjects \u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cmeta charset=\"UTF-8\"\u003e\n\u003ch3\u003ePatient care\u003c\/h3\u003e\n\u003ch4\u003eAerogen improves patient care in response to aerosolised medication\u003csup\u003e9-11\u003c\/sup\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan\u003eIn studies assessing bronchodilator delivery across several respiratory modalities, Aerogen Solo, when compared with jet nebulisers, was associated with:\u003c\/span\u003e\n\u003c\/h4\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cspan\u003eImprovements in lung function in patients undergoing NIV\u003csup\u003e†9\u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eComparable bronchodilator efficacy\u003csup\u003e‡ \u003c\/sup\u003eduring HF\u003csup\u003e10\u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cspan\u003eReductions in hospital admission rates, emergency department median length of stay, and in the number of treatments and time required to achieve symptom control\u003csup\u003e§ \u003c\/sup\u003e in SV patients\u003csup\u003e¶11 \u003c\/sup\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003csup\u003e†\u003c\/sup\u003eBetween-group difference in FEV\u003csub\u003e1\u003c\/sub\u003e, FVC, breathlessness score, RR, and PaCO\u003csub\u003e2\u003c\/sub\u003e from  baseline to 120 minutes in patients with acute exacerbation of COPD\u003cbr\u003e\u003csup\u003e‡\u003c\/sup\u003eAs defined by relative increase in FEV\u003csub\u003e1\u003c\/sub\u003e in patients with reversible obstructive lung disease\u003cbr\u003e\u003csup\u003e§\u003c\/sup\u003eDefined as achieving a mild asthma score following an asthma exacerbation\u003c\/span\u003e\u003c\/p\u003e\n\u003ch3\u003eWorkflow\u003c\/h3\u003e\n\u003ch4\u003eAerogen simplifies the workflow\u003c\/h4\u003e\n\u003cdiv\u003e\n\u003cul\u003e\n\u003cli\u003eAerogen Solo is a closed-circuit aerosol drug delivery system,\u003csup\u003e2\u003c\/sup\u003e which eliminates the need to open the circuit when administering medication during IMV or NIV  \u003c\/li\u003e\n\u003cli\u003eAerogen Solo delivers integrated aerosol delivery with HF and can be used in conjunction with Aerogen Ultra for aerosol drug delivery in SV patients\u003csup\u003e2\u003c\/sup\u003e\u003cbr\u003e\n\u003c\/li\u003e\n\u003cli\u003eAerogen Solo is intended for the aerosolisation of physician-prescribed medications for inhalation which are approved for use with a general purpose nebuliser\u003csup\u003e2\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003cli\u003eOne system can be used throughout a patient's respiratory journey (IMV, NIV, HF, SV),\u003csup\u003e2\u003c\/sup\u003e supporting continuity of care\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"AEROGEN","offers":[{"title":"Default Title","offer_id":54981251563900,"sku":"AG-AS3200","price":455.0,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0628\/9575\/1325\/files\/image_f9805bfa-3fdd-4cbb-bc8a-900a4ba24512.jpg?v=1740658436"}],"url":"https:\/\/www.capabledirect.co.uk\/collections\/aerogen.oembed","provider":"Capable Direct","version":"1.0","type":"link"}